powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1023524600
Romana Kanta
MD
Endocrinology
Brooklyn,
NY
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
QUALITY · MIPS · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
4,704
Beneficiaries
—
Total drug cost
$2.4M
Distinct drugs
39
Brand share
63.4%
Top prescribed drugs
Semaglutide
616 claims
Levothyroxine Sodium
371 claims
Insulin Aspart
364 claims
Empagliflozin
339 claims
Glimepiride
263 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
209
Unique beneficiaries
—
Total services
284
Distinct HCPCS
3
Medicare payment
$27K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 627 Endocrinology providers in NY — below median (cohort median 837).